Vaccination Against SARS-Cov-2 among Patients with Parkinson’s Disease Based on the Results of COVPARK-LT Study
Background. COVID-19 in patients with Parkinson’s disease leads to worsening of symptoms and development of severe/critical conditions; its long-term consequences are still being investigated. Data on vaccination against SARS-Cov-2 in Parkinson’s disease are inconsistent. There are no publications o...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Vilnius University Press
2024-02-01
|
| Sarja: | Neurologijos seminarai |
| Aiheet: | |
| Linkit: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/34584 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|